scholarly article | Q13442814 |
P50 | author | Toshihiko Fujimori | Q39569662 |
Akihiro Umezawa | Q86645855 | ||
P2093 | author name string | Yo-Ichi Nabeshima | |
Takeshi Oya | |||
Tomoatsu Kimura | |||
Yoko Ishii | |||
Masakiyo Sasahara | |||
Masahiko Kanamori | |||
Hiraku Motomura | |||
Shin Ishizawa | |||
Ayano Tokunaga | |||
Chieko Nakamura | |||
P433 | issue | 9 | |
P304 | page(s) | 1519-1528 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
P1476 | title | PDGF receptor beta is a potent regulator of mesenchymal stromal cell function | |
P478 | volume | 23 |
Q48841601 | Aberrant hippocampal spine morphology and impaired memory formation in neuronal platelet-derived growth factor β-receptor lacking mice |
Q33986004 | Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal |
Q51786482 | Blood clot formed on rough titanium surface induces early cell recruitment. |
Q49957630 | Bone intramedullary reaming grafts the fracture site with CD146+ skeletal progenitors and downmodulates the inflammatory environment |
Q28659195 | Bone regeneration and stem cells |
Q93046137 | CD140b (PDGFRβ) signaling in adipose-derived stem cells mediates angiogenic behavior of retinal endothelial cells |
Q37085580 | CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism |
Q36176132 | Cell-based therapy for prevention and reversal of myocardial remodeling |
Q35216154 | Circulating stem cell vary with NYHA stage in heart failure patients |
Q43498242 | Controlling the proliferation and differentiation stages to initiate periodontal regeneration. |
Q28730433 | Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects |
Q38994808 | Decoding Telocytes |
Q51066955 | Delayed fracture healing in tetranectin-deficient mice. |
Q54568475 | Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice. |
Q28729211 | Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells |
Q37253278 | Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model. |
Q41205329 | Effect of PDGF, IGF-1 and PRP on the implant osseointegration. An histological and immunohistochemical study in rabbits |
Q84041689 | Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors |
Q24599620 | Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells |
Q37673359 | Evaluation of functional dynamics during osseointegration and regeneration associated with oral implants |
Q44998864 | Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c |
Q35101099 | Function and regulation of primary cilia and intraflagellar transport proteins in the skeleton |
Q34318054 | Growth factor regulation of proliferation and survival of multipotential stromal cells |
Q41788059 | Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells |
Q33625560 | Hybrid photopatterned enzymatic reaction (HyPER) for in situ cell manipulation |
Q31068753 | Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells. |
Q92504832 | Identification of biological pathways and genes associated with neurogenic heterotopic ossification by text mining |
Q39459161 | Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro |
Q31141743 | In situ cell manipulation through enzymatic hydrogel photopatterning. |
Q35085531 | Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells |
Q37595534 | Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing |
Q55006647 | Leukocyte-Poor Platelet-Rich Plasma-Derived Growth Factors Enhance Human Fibroblast Proliferation In Vitro. |
Q38824445 | Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential |
Q26865070 | Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease |
Q37366495 | Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growth |
Q38336568 | MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow |
Q42920218 | Modeling Bone Marrow Toxicity Using Kinase Structural Motifs and the Inhibition Profiles of Small Molecular Kinase Inhibitors |
Q33379619 | Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling |
Q64264193 | PDGF Modulates BMP2-Induced Osteogenesis in Periosteal Progenitor Cells |
Q34627291 | PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling |
Q33578192 | PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. |
Q39433494 | PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells |
Q35895790 | PDGFB-based stem cell gene therapy increases bone strength in the mouse |
Q36350600 | PDGFRα plays a crucial role in connective tissue remodeling. |
Q38844997 | Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor |
Q37719207 | Periodontal-ligament-derived stem cells exhibit the capacity for long-term survival, self-renewal, and regeneration of multiple tissue types in vivo. |
Q37491972 | Periosteum: biology and applications in craniofacial bone regeneration |
Q42242005 | Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of activ |
Q35995598 | Platelet-Derived Growth Factor BB Enhances Osteogenesis of Adipose-Derived But Not Bone Marrow-Derived Mesenchymal Stromal/Stem Cells |
Q37052102 | Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cells |
Q50003007 | Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property |
Q51003781 | Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression. |
Q47215693 | Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation |
Q51362207 | Regulatory Effects of Urokinase on Mesenchymal Stromal Cell Migration, Proliferation, and Matrix Metalloproteinase Secretion. |
Q42797555 | STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ. |
Q54271815 | Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. |
Q43059186 | Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro. |
Q34403310 | The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice. |
Q39356695 | The roles of signaling pathways in bone repair and regeneration |
Q106642644 | Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell |
Q38757625 | miR-106b-5p and miR-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation |
Search more.